Table: begin end state 1 16 cytoplasmic 17 30 non-cytoplasmic 31 53 transmembrane 54 59 cytoplasmic 60 80 transmembrane 81 91 non-cytoplasmic 92 112 transmembrane 113 115 cytoplasmic 116 133 transmembrane 134 159 non-cytoplasmic 160 181 transmembrane 182 189 cytoplasmic 190 213 transmembrane 214 232 non-cytoplasmic 233 256 transmembrane 257 268 cytoplasmic 269 293 transmembrane 294 315 non-cytoplasmic 316 339 transmembrane 340 370 cytoplasmic 371 388 transmembrane 389 393 non-cytoplasmic 394 413 transmembrane 414 424 cytoplasmic 425 444 transmembrane 445 449 non-cytoplasmic 450 470 transmembrane 471 479 cytoplasmic
Input: >N515DRAFT_0722 MSLIRSLFAVKPVEASLTADDSLRRTLGLKELVVLGVGAVIGAGIFVITGQAAAEHAGPA LTLSFVLAGLAAALAALSYAEFAAMLPVSGSAYVYAYATFGELLAWFIGWNVVAEYLLAV SSVAVGWSGYGVGLLKSLGIEVPAALANAPLSFKDGHLELTGALLNLPALLVVAALTALL YRGTRQSTMFASVVVALKVIVVVLFVVCGLQYVDPSLWHPYVPANQGGDHYGWAGVFRAA TSVFYAYIGFDAVATAAQETRNPQRNVPAGILISLAICTVLYIIVAAVLTGLVPYPQLAT AEPVATALAAHPPLAWLKLLTQVGAVAGLTSVILVMHLGLSRILYSMAGDGLLPTFFGAV HERHRTPHRTTLLVGAVGGVLAAVFPLSLLGDLLSMGTLLAFATVCIGVLVLRRTHPNLP RGFRVPAAPAVCTLGVLVCAFLLAQMNLGNWILLAAWTTLGMLIYIAYGYRHSLMRRRG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server